In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies

Since the first approval of monoclonal antibodies by the United States Food and Drug Administration (FDA) in 1986, therapeutic antibodies have become one of the predominant classes of drugs in oncology and immunology. Despite their natural function in contributing to antiviral immunity, antibodies a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagant, Silvere, Liberatore, Rachel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618954/
https://www.ncbi.nlm.nih.gov/pubmed/34834297
http://dx.doi.org/10.3390/pharmaceutics13111882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618954/
https://www.ncbi.nlm.nih.gov/pubmed/34834297
http://dx.doi.org/10.3390/pharmaceutics13111882

Ejemplares similares